AI Blood Test Detects Early Liver Disease

Researchers at Johns Hopkins developed an AI-driven blood test to detect early-stage liver disease ^[1][2]. The liquid biopsy scans DNA fragments to identify markers of liver fibrosis and cirrhosis years before symptoms develop ^[1][3]. This marks the first time fragmentome technology has been applied to chronic non-cancer diseases ^[2]. Current diagnostic methods often require invasive biopsies or imaging that may miss early signs of scarring ^[2]. The new AI model analyzes "fragmentomes," which are patterns of cell-free DNA released into the bloodstream ^[3]. This approach could provide a scalable way to screen millions of people at risk for chronic liver conditions ^[1].